COLOBC Stock Overview
Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Coloplast A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 649.40 |
| 52 Week High | DKK 956.20 |
| 52 Week Low | DKK 644.90 |
| Beta | 0.58 |
| 1 Month Change | -8.87% |
| 3 Month Change | -18.80% |
| 1 Year Change | -23.09% |
| 3 Year Change | -23.69% |
| 5 Year Change | -37.74% |
| Change since IPO | 212.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| COLOBC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -10.8% | -1.3% | -0.3% |
| 1Y | -23.1% | 0.6% | -0.7% |
Return vs Industry: COLOBC underperformed the UK Medical Equipment industry which returned 0.6% over the past year.
Return vs Market: COLOBC underperformed the UK Market which returned -0.4% over the past year.
Price Volatility
| COLOBC volatility | |
|---|---|
| COLOBC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in GB Market | 10.9% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: COLOBC's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine COLOBC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 16,741 | n/a | www.coloplast.com |
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
Coloplast A/S Fundamentals Summary
| COLOBC fundamental statistics | |
|---|---|
| Market cap | DKK 144.15b |
| Earnings (TTM) | DKK 4.54b |
| Revenue (TTM) | DKK 27.79b |
31.7x
P/E Ratio5.2x
P/S RatioIs COLOBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COLOBC income statement (TTM) | |
|---|---|
| Revenue | DKK 27.79b |
| Cost of Revenue | DKK 9.03b |
| Gross Profit | DKK 18.77b |
| Other Expenses | DKK 14.22b |
| Earnings | DKK 4.54b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 19, 2025
| Earnings per share (EPS) | 20.18 |
| Gross Margin | 67.52% |
| Net Profit Margin | 16.35% |
| Debt/Equity Ratio | 137.2% |
How did COLOBC perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield109%
Payout RatioDoes COLOBC pay a reliable dividends?
See COLOBC dividend history and benchmarks| Coloplast dividend dates | |
|---|---|
| Ex Dividend Date | May 08 2025 |
| Dividend Pay Date | May 12 2025 |
| Days until Ex dividend | 3 days |
| Days until Dividend pay date | 1 day |
Does COLOBC pay a reliable dividends?
See COLOBC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/10 15:24 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Coloplast A/S is covered by 49 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Robert Bate | Barclays |
| Hassan Al-Wakeel | Barclays |